This inventor holds 3 USPTO granted patents. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1976-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JA (1976 - 1977)
- Tokyo, JP (1982)
Company Filing History:
Years Active: 1976-1982
Title: The Innovations of Yoshio Hiramatsu
Introduction
Yoshio Hiramatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of three patents to his name, Hiramatsu's work focuses on innovative processes that enhance the efficacy of antiulcerative medicines.
Latest Patents
Hiramatsu's latest patents include a process for the production of 1-aryloxy-aminopropane derivatives. This process involves the preparation of 1-aryloxy-3-aminopropane derivatives and their acid addition salts. The method comprises the ring opening of tertiary azetidinol derivatives. These compounds exhibit beta-adrenergic blocking activity and have the potential to control gastric juice secretion, making them useful in treating peptic and duodenal ulcers.
Career Highlights
Yoshio Hiramatsu is currently associated with Teikoku Hormone Mfg. Co., Ltd. His work at this company has allowed him to focus on the development of innovative pharmaceutical solutions. Hiramatsu's expertise in the field has led to advancements that benefit patients suffering from gastrointestinal disorders.
Collaborations
Hiramatsu has collaborated with notable colleagues, including Kunio Tsukamoto and Yasushi Suzuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yoshio Hiramatsu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His innovative processes are paving the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile